Αποτελέσματα Αναζήτησης
20 Αυγ 2021 · This guideline covers obstructive sleep apnoea/hypopnoea syndrome (OSAHS), obesity hypoventilation syndrome (OHS), and chronic obstructive pulmonary disease (COPD) with OSAHS overlap syndrome, providing advice on investigating and managing these related conditions.
- Obesity Hypoventilation Syndrome - PMC - PubMed Central (PMC)
Obesity hypoventilation syndrome is a respiratory...
- Obesity Hypoventilation Syndrome - PMC - PubMed Central (PMC)
CPAP is considered the first-line treatment modality for OHS phenotype with concomitant severe obstructive sleep apnoea, whereas NIV is preferred in the minority of OHS patients with hypoventilation during sleep with no or milder forms of obstructive sleep apnoea (approximately <30% of OHS patients).
Background Obesity hypoventilation syndrome (OHS) is treated with either non-invasive ventilation (NIV) or CPAP, but there are no long-term cost-effectiveness studies comparing the two treatment modalities.
23 Φεβ 2016 · Patients with obesity hypoventilation syndrome have poor quality of life and are at great risk for excess hospitalization and premature mortality because of cardiopulmonary complications including exacerbation of respiratory and congestive heart failure.
If the sleep evaluation demonstrates OHS and severe obstructive sleep apnea (OSA) (apnea–hypopnea index ≥ 30), the panel recommends continuous positive airway pressure (CPAP) titration and treatment.
Obesity hypoventilation syndrome is a respiratory consequence of morbid obesity that is characterized by alveolar hypoventilation during sleep and wakefulness. The disorder involves a complex interaction between impaired respiratory mechanics, ventilatory drive and sleep-disordered breathing.
1 Νοε 2020 · CPAP is simpler to implement and is less costly than NIV. 24 To investigate which of the two treatments is more cost-effective, the only study reported is from Masa and cols, whom carried out a post hoc, within-trial, cost-effectiveness analysis using the large multicentre, open-labelled, randomised controlled study (Pickwick study) 3, 24, 43 ...
